Literature DB >> 16391422

Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats.

Z Rogóz1, G Skuza, B Legutko.   

Abstract

Recent studies indicate a role of the brain-derived neurotrophic factor (BDNF) in the pathophysiology of depression, as well as in the mechanism of action of antidepressant drugs (ADs). It has been shown that serum BDNF levels are decreased in depressed patients. Moreover, antidepressant treatment increases serum BDNF levels and it is positively correlated with medication response. In addition, repeated administration of ADs induces an increase in rat hippocampal or cortical BDNF gene expression. Since the most potent effect of ADs on BDNF gene expression was found after prolonged treatment, in the present study we investigated the influence of repeated treatment (twice daily for 14 days) of the new AD mirtazapine (5 or 10 mg/kg) on BDNF mRNA level (the Northern blot) in rat hippocampus and cerebral cortex. Imipramine was used as a reference compound. The experiment was carried out on male Wistar rats. The tissue for biochemical assays was collected 24 h after the last doses of mirtazapine and imipramine. We also studied the effect of repeated mirtazapine on the action of the 5-HT2A receptor agonist (+/-)DOI in the behavioral test (head twitches induced by (+/-)DOI) in rats. The obtained results showed that, like imipramine (10 mg/kg), mirtazapine (10 mg/kg) increased BDNF gene expression in both the examined brain regions: in the hippocampus by 24.0 and 26.5%, in the cerebral cortex by 29.9 and 41.5%, respectively, compared with the vehicle-treated control. Neither mirtazapine nor imipramine administered repeatedly at a lower dose (5 mg/kg) significantly changed BDNF mRNA levels in the hippocampus and cerebral cortex. Repeated treatment with mirtazapine (10, but not 5 mg/kg) inhibited the behavioral syndrome induced by (+/-)DOI. This study provides first conclusive evidence that repeated mirtazapine administration increases BDNF mRNA levels; moreover, it indicates that the enhancement of BDNF gene expression may be essential for the clinical effect of mirtazapine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16391422

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  21 in total

Review 1.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

2.  Mirtazapine inhibits tumor growth via immune response and serotonergic system.

Authors:  Chun-Kai Fang; Hong-Wen Chen; I-Tsang Chiang; Chia-Chieh Chen; Jyh-Fei Liao; Ton-Ping Su; Chieh-Yin Tung; Yosuke Uchitomi; Jeng-Jong Hwang
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

Review 3.  Neurotrophin strategies for neuroprotection: are they sufficient?

Authors:  Joseph P Steiner; Avindra Nath
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-08       Impact factor: 4.147

Review 4.  New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases.

Authors:  Naoki Adachi; Tadahiro Numakawa; Misty Richards; Shingo Nakajima; Hiroshi Kunugi
Journal:  World J Biol Chem       Date:  2014-11-26

5.  Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: Role of inflammatory cytokines and nitric oxide.

Authors:  Mohammad Taghi Mansouri; Bahareh Naghizadeh; Behnam Ghorbanzadeh; Neda Amirgholami; Gholamreza Houshmand; Soheila Alboghobeish
Journal:  Metab Brain Dis       Date:  2019-10-19       Impact factor: 3.584

6.  Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

Authors:  J Wong; T M Hyde; H L Cassano; A Deep-Soboslay; J E Kleinman; C Shannon Weickert
Journal:  Neuroscience       Date:  2010-05-27       Impact factor: 3.590

7.  Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats.

Authors:  Robin M Voigt; Amanda L Mickiewicz; T Celeste Napier
Journal:  Behav Brain Res       Date:  2011-07-12       Impact factor: 3.332

8.  Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression.

Authors:  Britta Haenisch; Andras Bilkei-Gorzo; Marc G Caron; Heinz Bönisch
Journal:  J Neurochem       Date:  2009-08-18       Impact factor: 5.372

Review 9.  Involvement of brain-derived neurotrophic factor in late-life depression.

Authors:  Yogesh Dwivedi
Journal:  Am J Geriatr Psychiatry       Date:  2013-03-19       Impact factor: 4.105

10.  Brain-derived neurotrophic factor: role in depression and suicide.

Authors:  Yogesh Dwivedi
Journal:  Neuropsychiatr Dis Treat       Date:  2009-08-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.